LDN Video Interviews and Presentations

Elizabeth - Scotland: Fibromyalgia (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Elizabeth from Scotland uses LDN for Fibromyalgia.

After travelling to Greece she started feeling very tired, constantly with flu like symptoms, no energy and a lot of aches and pains.

After taking LDN, Elizabeth states that her pain levels decreased and her mood got brighter. She has a much better quality of life now.

Play the video to listen to the whole story.

Elizabeth (2) - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I'd like to introduce Elizabeth from England, who has multiple sclerosis; welcome Elizabeth.

Elizabeth: Hello

Linda Elsegood: Could you tell us when you first started to notice MS. Symptoms?

Elizabeth: Well, I didn't that they were there, but I didn't really take any enough to support them. I think, um, they started after I had glandular fever in my when I was a teenager, but so I'm not particularly aware, so

I didn't think it was strange that I would fall over and, um, I had very bad headaches.

So I never thought it was strange. So it was my husband that took me to the doctors. He thought there was something wrong with me, and the doctor thought it was oxygen deprivation at birth.

That's why I was a bit wobbly, but I never thought I had any. Well, I certainly do recognize, and there was something wrong with me. And neither did my family. And so it was a complete surprise when I was diagnosed with MS, after a brain scan

Linda Elsegood: And what age were you at the time you had?

Elizabeth: 32. I'm 44 now 32.

Linda Elsegood: So how does that affect your mind being told you have MS.

Elizabeth: Well, It just made me, well, it had this effect on me of just going into complete denial and going back to work and working very hard and just kind of pretending.

I'm just going to carry on with my career because I had a very successful career. And I was a bit upset. I was just to do a job in Singapore, and when I was diagnosed, well, they wouldn't let me fly. So we struck into the hospital. So I was upset that I couldn't do this high profile job in Singapore.

Um, um, the people that I work with, um, after the diagnosis, they, they didn't really understand what it was. My boss gave me a very high powered project, which looking back probably wasn't the best thing today. And, and, and my father was very poorly at a time as well.

I'm an only child. So my family didn't really take much notice of the diagnosis because my father was a very serious man.

Linda Elsegood: what were your symptoms at the time you found LDN?

Elizabeth: Well, pain in the night, like, um, pain in my head as well.

Linda Elsegood: Um, when did you find out the end?

Linda Elsegood: Um, did you manage to get your own doctor to prescribe LDN?

Elizabeth: No. No, because my doctor, I talked to her about when she said that she wasn't able to do that.

Linda Elsegood: So once you started, did you have any introductory side effects? and how long did it take for you to notice that LDN was doing anything for you? 

Elizabeth: let's say that's the primary thing, but I notice quite quickly, um, I'd say within. Within three, weeks of taking it.

Linda Elsegood: What about your other symptoms has LDN helped relieve any of those?

Elizabeth: So in terms of walking then still got problems in there. Like when I don't walk for a while, Um, had I seen a dramatic improvement.

So I don't have headaches. Like I used to have.

Linda Elsegood: Did you have any problems with your bladder?

Elizabeth: Yes. And yes. Optionally.

Linda Elsegood: fatigue,

Elizabeth: fatigue, um, goes in waves.

Linda Elsegood: So how would you feel, how would you say LDN has helped your quality of life?

Elizabeth: I wouldn't like to stop taking it, it's very good for me, LDN and really, I suppose the only true measure that I would be able to find this if I stopped taking it.

Linda Elsegood: Well, what would you say to other people who are contemplating trial at the end? That might be a little bit scared

Elizabeth. Well, I'd say you've got to try and to do the research and to look at all the testimonials. And then to make an informed choice. And I mean, I think politically the reason is nothing to do with the effectiveness of the drug, um, there's no money in it.

Linda Elsegood: Well, thank you very much for sharing your story with us, Elizabeth, and I hope you get all your problems sorted out soon.

Any questions or comments you may have, please contact us. I look forward to hearing from you. Thank you for joining us today. We really appreciated your company. Until next time, stay safe and keep well.

Elizabeth - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Elizabeth began experiencing symptoms in 1990 but wasn't diagnosed with MS until 2004.

She had a late diagnosis and wasn't actually diagnosed until 2004. She would have numbness in her legs lasting for a week or two, recurring every couple of years and gradually deteriorating until in 2004 she lost coordination and was unable to walk. After the diagnosis, she quickly advanced to the secondary progressive stage.

The diagnosis came as a relief as she thought she'd suffered a stroke.

Since taking Low Dose Naltrexone her life has improved considerably and she wishes she had commenced treatment earlier as her left leg is quite severely affected. Her quality of life has gone from 9 to 1 in terms of wellbeing and to 3 physically because of impairment. She now feels more relaxed, her walking is less jerky and, most importantly, within three days she recovered control of her bladder.

She heard about LDN from a fellow MS sufferer and decided to try it but was unable to get a prescription as it's off-license. 

She obtained it through Prescribe For Me.

She had no adverse side effects from LDN apart from disturbed sleep patterns and vivid dreams. She felt much better and more relaxed and knew the LDN was working within three days.

Her partner has even begun taking it as he is envious of her resistance to infections!

This is only a summary of the interview. To hear it in full click on the link.

Eileen - Ireland: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Eileen from Ireland, was diagnosed with Multiple Sclerosis(MS) at the age of 27. She experienced poor vision all of a sudden during a hockey match, so saw her GP. After a lumbar puncture she was diagnosed. Eileen also experienced fatigue and loss in ability to walk. She heard about LDN through a friend who forwarded her articles, which got Barbara looking further into it. She was prescribed Low Dose Naltrexone (LDN), and started taking the medication in November. Barbara says that it has lifted her fatigue and halted the progression of MS.

When asked what she would say to those contemplating taking LDN, Barbara replied with “go for it. Absolutely. No hesitation at all.” 

This is a summary to listen to the entire interview click the video link. 

Dr Wai Liu, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Wai Liu is from St. George’s Hospital in London UK. He had just published a paper on how low dose naltrexone (LDN) can affect certain cancer cell lines in the laboratory that hopefully will drive clinical trials, then get approval for LDN as a treatment for cancer.

They took cells from patients with certain forms of cancer and compared the effects on the gene expression profiles by LDN, and conventional-dose naltrexone. Genes involved in cell cycling, the way cancer cells can grow, can be controlled in the way they proliferate. They showed LDN could target certain genes responsible for the cell cycle, and if that was exploited, they might get a handle on how cancer would grow. Indeed, they showed LDN does slow the growth of certain cancer cells via its effect on these particular proteins. As well, they found that because of the effects on the cell cycle, LDN increased the proteins that controlled the ability of a cell to undergo cell death, and increase cell killing in those cancer cells.

Furthermore, after administering LDN for a few days followed by no LDN for a recovery phase, they found continued cell killing, something bizarre to them, but similar to what happens with other drugs such as cannabinoids, or a couple other agents. In certain situations they saw LDN as having no effect on cancer cells, but during the recovery phase, there was a much improved level of cell killing.

They also used different schedules of chemotherapy alongside LDN, like gemcitabine, oxaliplatin, and something else like cyclophosphamide, as they are proven cytotoxic agents. They showed on a laboratory petri dish level, that when using both LDN and a number of cytotoxic agents, there was a much-increased level of proteins such as BAX, that regulate the ability of a cancer cell to undergo cell death. Understanding the profile of how drugs work lets you predict the best drugs to combine with the drug you’re testing. So for example, using a form of chemotherapy that requires BAX to be present and LDN results in cooperation between two different drugs.

Dr. Liu is not aware of doctors using this information clinically. There are many anecdotal reports of how LDN can help alleviate cancer symptoms or help with cancer treatment. More research is needed to show the benefits of LDN in cancer patients, and in combination with various chemotherapies or immunotherapies. LDN does things to cancer cells, and people are beginning to see the value in LDN. The more people hear and read about LDN, and with an increasing amount of scientific literature to support LDN as a cancer therapy, the better chance to attract funding for clinical trials.

Summary from Dr. Wai Liu, listen to the video for the show.

Keywords: LDN, low dose naltrexone, cancer, chemotherapy, immunotherapy

Any questions or comments you may have, please contact us. I look forward to hearing from you. 

Dr Tom O’Bryan, LDN Radio Show 12 July 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Tom O'Bryan shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Wheat sensitivity can cause an immune response, not just gluten. Hydrochloric acid in the stomach breaks down the proteins and enzymes in the gut convert them to amino acids, which permeate the intestines and enter the bloodstream. Wheat causes increased intestinal permeability ("leaky gut") in everyone, but not everyone suffers from eating wheat because wheat is a minor irritant. At some point, symptoms of intestinal permeability are likely to appear due to loss of oral tolerance, and can result in various autoimmune disorders, such as Hashimoto's. Reducing dietary wheat can arrest the development of autoimmune disorders. A wheat-free diet is easier to follow when patients understand that inflammation can be reduced by following the diet. His book, The Autoimmune Fix, has recipes. For example, take 1 Tbsp chia seeds, which are high in Omega 3s, stir into coconut milk till it starts to gel, refrigerate, add crushed fruit, and you get a healthy dessert.

Dr Tom O’Bryan, LDN Radio Show 27 Sept 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Tom O'Bryan shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Tom O’Bryan discusses his book, The Autoimmune Fix. Expect continual OMGs.The prevalance of autoimmune disease is the #3 cause of getting sick and dying in the world. Autoimmune diseases progress over years, till enough tissue is damaged that enough symptoms appear to get a diagnosis. For example, a very early sign of Parkinson's is loss of sense of smell, and can be predictive of death within 5 years.

Measuring our antibodies can predict illness in its early stages. Antibodies cause cellular damage, then tissue damage, then inflammation, and eventually organ damage. 

Getting this in control early is important. Most of us are bombarded with toxins every day, so learning how to avoid them is crucial to a good healthy life. LDN is helpful in bolstering and regulating our immune system so that it can naturally fight off these elevated antibodies.

This interview includes some valuable knowledge for all listeners concerned with how to combat autoimmune diseases, cancers etc.

This is a summary of Dr Tom O’Bryan’s interview. Please listen to the rest of Dr O’Bryan’s story by clicking on the video above.

Dr Tom O’Bryan, LDN Radio Show 01 Feb 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Tom O’Bryan shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Tom O’Bryan is the founder of www.thedoctor.com and is an internationally recognized speaker and workshop leader specializing in non-celiac gluten sensitivity and celiac disease. He hosted the gluten summit, and stars in the documentary series, betrayal, featuring the autoimmune solutions. He’s also written a book called ‘The Autoimmune Fix’.

In this interview Dr O’Bryan explains his many years of analysis in terms of the effect our diet can have upon our immune systems and subsequent immune responses we have to autoimmune diseases. The over-consumption of products such as milk, wheat and dairy in general can be damaging and our diets must be moderated.

This is a summary of Dr Tom O’Bryan’s interview. Please listen to the rest of Dr O’Bryan’s story by clicking on the video above.

Dr Thomas Cowan, LDN Radio Show 14 Dec 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Thomas Cowan shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Thomas Cowan practices holistic medicine in San Francisco and prescribes Low Dose Naltrexone (LDN). He also has a new book called ‘Human Heart, Cosmic Heart’.

He first heard of LDN in 1992 from one of his patients with AIDS who requested it. This occurred again four years later, prompting Dr Cowan into researching LDN more thoroughly and learning about its many benefits in combating autoimmune diseases.

He says that LDN’s side effects are very uncommon and that in 95% of his autoimmune patients, he has prescribed LDN. Dr Cowan is a strong advocate of LDN.

This is a summary of Dr Thomas Cowan’s interview. Please listen to the rest of Dr Cowan’s interview by clicking on the video above.

Dr Thomas Cowan, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo

Dr Thomas Cowan shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Thomas Cowan first came across Low Dose Naltrexone (LDN) around 20 years ago when one of his close friends had incurable lymphoma. Having refused to continue on conventional treatment which had little to no effect on improving his health, he researched alternative treatments and came across LDN which drastically helped him to recover.

In the last decade of his career, Dr Cowan has predominantly treated patients with Ulcerative Colitis (UC) and Crohn’s Disease, finding that LDN can be successful in treating both diseases and providing great relief to his patients.

This is a summary of Dr Thomas Cowan’s interview. Please listen to the rest of Dr Cowan’s story by clicking on the video above.